MedTrace Logo

Oral Findings In A Group of Egyptian Children With Attention Deficit Hyperactivity Disorder

NCT03887039 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 78

Last updated 2019-04-16

No results posted yet for this study

Summary

Attention-deficit/hyperactivity disorder is the most common childhood neuro-developmental disorder that is characterized by inattention, hyperactivity, and impulsivity. These symptoms last till adulthood in 65% of cases. ADHD has been reported to have a worldwide prevalence of 5.3% and it is more common in boys than in girls (Ghanizadeh 2008; Serra-Negra et al. 2012 and Shooshtari et al. 2013) The symptoms of ADHD are generally treated through behavioral therapy, with or without pharmacological intervention. Medications prescribed are commonly divided into stimulant or non-stimulant drugs. The stimulant medications (such as methylphenidate and amphetamines) have been implicated in adverse oral effects, such as xerostomia and gingival enlargement. The current evidence is controversial regarding the severity and prevalence of dental caries, dental trauma, periodontal diseases, oral habits and tooth wear among patients with ADHD (Chau et al. 2017).

In the Arab world, few studies have been published on ADHD. Accordingly, in the Arab society and Egypt there are limited data regarding the oral findings of children with ADHD. Owing to the sparsity of these data, this study will be conducted to evaluate different oral characteristics of Egyptian children with ADHD.

Conditions

  • Oral Manifestations

Interventions

OTHER

clinical examination

clinical examination for all the oral findings

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Sara G Hussien, BSc · Resident at pediatric Dentistry and Dental Public Health Department

  • Randa Y Abdel Gawad, PhD · Associate professor at pediatric Dentistry and Dental Public Health Department

Eligibility

Min Age
3 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-31
Primary Completion
2020-06-30
Completion
2020-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03887039 on ClinicalTrials.gov